CYP19A1 and polycystic ovary syndrome: From a practical standpoint, the use of aromatase inhibitors may be an option before IVF/ICSI after counseling and the consent of the couple in specific cases of women with CC-resistant PCOS without other infertility factors and for whom the high-complexity treatment is cost-prohibitive 41.